Screener
Fennec Pharmaceuticals FENC Q3 2026 earnings
Reported November 12, 2026 · Before market open
Revenue$19.6MBeat by $740.4K
EPS$0.12Beat by $0.02
Revenue estimate$18.9M
EPS estimate$0.10
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Fennec Pharmaceuticals report Q3 2026 earnings?
- Fennec Pharmaceuticals (FENC) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Fennec Pharmaceuticals's Q3 2026 revenue and EPS?
- Fennec Pharmaceuticals reported revenue of $19.6M and eps of $0.12 for Q3 2026.
- Did Fennec Pharmaceuticals beat estimates in Q3 2026?
- Revenue beat the consensus estimate of $18.9M by $740.4K. EPS beat the consensus estimate of $0.10 by $0.02.
- How did Fennec Pharmaceuticals's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 57.3% from $12.5M a year earlier.
- Where can I find Fennec Pharmaceuticals's Q3 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-126203) directly on SEC EDGAR. The filing index links above go to sec.gov.
